Clinical Trial

Omalizumab Weight-Based Dosing Efficacy Trial

Name: Omalizumab Weight-Based Dosing Efficacy Trial — clinical trial record (NCT06943534)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OWED-T

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This research is being conducted to assess the safety and effectiveness of increased dosing of Omalizumab for food allergies.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-04-16; most recent amendment 2026-02-03.

Status change: Not Yet Recruiting → Recruiting 2025-05-30

Trial Details

NCT Number	NCT06943534
Lead Sponsor	Massachusetts General Hospital
Conditions	Allergies, Food Allergy
Enrollment	30 participants
Start Date	2025-07-03
Primary Completion	2027-05-01 (estimated)
Study Completion	2028-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-05